Immunai, AstraZeneca collaborate to optimize cancer clinical trialsUnder the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.Cancer (Illustrative)(photo credit: INGIMAGE)
